Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 223 Records) |
Query Trace: Neoplasms and IDH1[original query] |
---|
Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. ESMO open 2022 12 7 (6): 100641. Murugesan K, Necchi A, Burn T C, Gjoerup O, Greenstein R, Krook M, López J A, Montesion M, Nimeiri H, Parikh A R, Roychowdhury S, Schwemmers S, Silverman I M, Vogel |
Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 9 . Tin-Yun Tang, Federico Nichetti, Benjamin Kaplan, Sara Lonardi, Filippo Pietrantonio, Lisa Salvatore, Caterina Vivaldi, Lorenza Rimassa, Filippo de Braud, Mario Domenico Rizzato, Dean Pavlick, Randy Chu, Anaemy Danner De Armas, Radwa Sharaf, Ethan Sokol, Jordi Rodon Ahnert, Jeffrey S Ross, Milind Javle, Monica Nig |
Glioma genetic profiles associated with electrophysiologic hyperexcitability. Neuro-oncology 2023 9 . Steven Tobochnik, Maria Kristina C Dorotan, Hia S Ghosh, Emily Lapinskas, Jayne Vogelzang, David A Reardon, Keith L Ligon, Wenya Linda Bi, Stelios M Smirnakis, Jong Woo L |
Comprehensive analyses of the clinicopathological features and genomic mutations of combined hepatocellular-cholangiocarcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 2023 9 . Takashi Ito, Takamichi Ishii, Haruhiko Takeda, Shinji Sumiyoshi, Katsuhiro Tomofuji, Satoshi Wakama, Kenta Makino, Hiroshi Horie, Ken Kumagai, Atsushi Takai, Elena Yukie Uebayashi, Satoshi Ogiso, Ken Fukumitsu, Hironori Haga, Hiroshi Seno, Etsuro Hata |
Identification of prognostic and driver gene mutations in acute myeloid leukemia by a bioinformatics analysis. Translational cancer research 2023 7 12 (6): 1552-1564. Lifang Li, Jingxiong Ruan, Ning Zhang, Jia Dai, Xin Xu, Xudong Tian, Jian |
Development and validation of an immune infiltration/tumor proliferation-related Notch3 nomogram for predicting survival in patients with primary glioblastoma. Frontiers in genetics 2023 6 14 1148126. Zong-Qing Zheng, Guo-Guo Zhang, Gui-Qiang Yuan, Jia-Hui Hao, Qian-Qian Nie, Ming-Cheng Zheng, Zhong Wa |
Isocitrate Dehydrogenase 1 and 2 Mutations in Pediatric Neuroblastoma Patients. Medeniyet medical journal 2023 6 38 (2): 102-110. Emre Leventoglu, Gurses Sahin, Sule Yesil, Ceyhun Bozkurt, Nazmiye Yuksek, Ali Fettah, Sule Toprak, Burcak Kurucu Bilgin, Emre Capkinoglu, Nilgun Eroglu, Sibel Akpinar Tekgunduz, Ayse Ulya Ert |
lncRNA TRHDE-AS1 Correlated with Genomic Landscape and Clinical Outcome in Glioma. Genes 2023 5 14 (5): . Jinxuan Xie, Yi Lin, Yajie Li, Aizhong Fang, Xin Li, Songlin Wang, Wenbin |
Identification of Prominent Genes between 3D Glioblastoma Models and Clinical Samples via GEO/TCGA/CGGA Data Analysis. Biology 2023 5 12 (5): . Brandon Wee Siang Phon, Saatheeyavaane Bhuvanendran, Qasim Ayub, Ammu Kutty Radhakrishnan, Muhamad Noor Alfarizal Kamarud |
Association of social deprivation with survival in younger adult patients with AML: an Alliance study. Blood advances 2023 5 . Melanie Rebechi, Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Alice S Mims, James S Blachly, Shelley Orwick, Karilyn Larkin, Christopher C Oakes, Andrew Hantel, Andrew J Carroll, William Blum, Bayard L Powell, Geoffrey L Uy, Richard M Stone, Richard A Larson, John C Byrd, Electra D Paskett, Jesse J Plascak, Ann-Kathrin Eisfe |
Therapeutic yield of extensive molecular profiling in cholangiocarcinoma: a retrospective single-center study. Journal of cancer research and clinical oncology 2023 5 . Justine Vancanneyt, Bie Wilmsen, Caroline Luyten, Chris Verslype, Eric Van Cutsem, Tania Roskams, Sabine Tejpar, Isabelle Vanden Bempt, Jeroen Dekerv |
Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer. Frontiers in oncology 2023 4 13 1160673. Nicolazzo Chiara, Magri Valentina, Marino Luca, Belardinilli Francesca, Di Nicolantonio Federica, De Renzi Gianluigi, Caponnetto Salvatore, De Meo Michela, Giannini Giuseppe, Santini Daniele, Cortesi Enrico, Gazzaniga Pao |
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma. Cancer research communications 2023 3 3 (2): 192-201. Fanucci Kristina, Pilat Mary Jo, Shyr Derek, Shyr Yu, Boerner Scott, Li Jing, Durecki Diane, Drappatz Jan, Puduvalli Vinay, Lieberman Frank Scott, Gonzalez Javier, Giglio Pierre, Ivy S Percy, Bindra Ranjit S, Omuro Antonio, LoRusso Patric |
Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors. JCO precision oncology 2023 3 7 e2200583. Aldea Mihaela, Tagliamento Marco, Bayle Arnaud, Vasseur Damien, Vergé Véronique, Marinello Arianna, Danlos François-Xavier, Blanc-Durand Felix, Bernard Elsa, Cerbone Luigi, Mosele Maria Fernanda, Renneville Aline, Hadoux Julien, Loriot Yohann, Sakkal Madona, Vozy Aurore, Sarkozy Clementine, Smolenschi Cristina, Nicotra Claudio, Martin-Romano Patricia, Boccon-Gibod Clementine, Habza Wafikaamira, Lazarovici Julien, Ponce Santiago, Hollebecque Antoine, Marzac Christophe, Lacroix Ludovic, Barlesi Fabrice, André Fabrice, Besse Benjamin, Rouleau Etienne, Italiano Antoine, Micol Jean-Baptis |
Distinct IDH1/2-associated Methylation Profile and Enrichment of TP53 and TERT Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma. Cancer research communications 2023 3 3 (3): 431-443. Dermawan Josephine Kam Tai, Nafa Khedoujia, Mohanty Abhinita, Xu Yingjuan, Rijo Ivelise, Casanova Jacklyn, Villafania Liliana, Benhamida Jamal, Kelly Ciara M, Tap William D, Boland Patrick J, Fabbri Nicola, Healey John H, Ladanyi Marc, Lu Chao, Hameed Mee |
The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia. Cancer medicine 2023 3 . Chen Xian, Tian Chuchu, Hao Zhuanghui, Pan Lingang, Hong Minglin, Wei Wei, Muyey Daniel Muteb, Wang Hongwei, Chen Xiuh |
Glycyl-tRNA Synthetase (GARS) Expression Is Associated with Prostate Cancer Progression and Its Inhibition Decreases Migration, and Invasion In Vitro. International journal of molecular sciences 2023 3 24 (5): . Khosh Kish Ealia, Gamallat Yaser, Choudhry Muhammad, Ghosh Sunita, Seyedi Sima, Bismar Tarek |
Oncogenic IDH1 Mutation Imparts Therapeutically Targetable Metabolic Dysfunction in Multiple Tumor Types. Cancer discovery 2023 2 13 (2): 266-268. Robinson Troy M, Levine Ross |
Determination of TMPRSS2-ERG, SPOP, FOXA1, and IDH1 prostate cancer molecular subtypes in Colombian patients and their possible implications for prognosis. Cell biology international 2023 2 . Montero-Ovalle Wendy, Sanabria-Salas María C, Mesa-López de Mesa Jorge, Varela-Ramírez Rodolfo, Segura-Moreno Yenifer Y, Sánchez-Villalobos Santiago A, Nuñez-Lemus Marcela, Serrano Martha |
Metabolic Modeling Identifies a Novel Molecular Type of Glioblastoma Associated with Good Prognosis. Metabolites 2023 2 13 (2): . Shen Qiu, Yang Hua, Kong Qing-Peng, Li Gong-Hua, Li |
Identification of a Novel Gene Signature Based on Kinesin Family Members to Predict Prognosis in Glioma. Medicina (Kaunas, Lithuania) 2023 2 59 (2): . Pan Dongxiao, Fang Xixi, Li Jipi |
Gene mutation analysis using next-generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi-center study from China. Cancer medicine 2023 2 . Li Junnan, Pei Li, Liang Simin, Xu Shuangnian, Wang Yi, Wang Xiao, Liao Yi, Zhan Qian, Cheng Wei, Yang Zesong, Tang Xiaoqiong, Zhang Hongbin, Xiao Qing, Chen Jianbin, Liu Lin, Wang |
Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01. Cancer science 2023 2 . Hosono Naoko, Chi SungGi, Yamauchi Takahiro, Fukushima Kentaro, Shibayama Hirohiko, Katagiri Seiichiro, Gotoh Akihiko, Eguchi Motoki, Morishita Takanobu, Ogasawara Reiki, Kondo Takeshi, Yanada Masamitsu, Yamamoto Kazuhito, Kobayashi Tsutomu, Kuroda Junya, Usuki Kensuke, Utsu Yoshikazu, Yoshimitsu Makoto, Ishitsuka Kenji, Ono Takaaki, Takahashi Naoto, Iyama Satoshi, Kojima Kensuke, Nakamura Yukinori, Fukuhara Suguru, Izutsu Koji, Abutani Hikaru, Yamauchi Nobuhiko, Yuda Junichiro, Minami Yosuke, |
The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour Microenvironment. Biologics : targets & therapy 2023 2 17 15-22. Kurdi Maher, Mulla Nasser, Katib Yousef, Alsinani Taghreed, Hakamy Sahar, Mj Addas Bassam, Malibary Husam, Halawa Taher F, S Farhan Marwa, Faizo Eyad, Baeesa Sal |
Druggable genomic landscapes of high-grade gliomas. Frontiers in medicine 2023 12 10 1254955. Paola Ghanem, Maria Fatteh, David Olayinka Kamson, Archana Balan, Michael Chang, Jessica Tao, Jaishri Blakeley, , Jenna Canzoniero, Stuart A Grossman, Kristen Marrone, Karisa C Schreck, Valsamo Anagnost |
Mutation analysis of the TERT gene in ovarian cancer patients of the Turkish population by next generation sequencing method. Cellular and molecular biology (Noisy-le-Grand, France) 2023 11 69 (11): 51-55. Betul Capar Gorali, Seda Gulec Y?lmaz, Fatma Tuba Akdeniz, Rukset Attar, Turgay ?sb |
Molecular profile and clinical features of patients with gliomas using a broad targeted next generation-sequencing panel. Oncology letters 2023 1 25 (1): 38. Romanidou Ourania, Apostolou Paraskevi, Kouvelakis Kyriakos, Tsangaras Kyriakos, Eliades Alexia, Achilleos Achilleas, Loizides Charalambos, Lemesios Christos, Ioannides Marios, Kypri Elena, Koumbaris George, Papadopoulou Kyriaki, Papathanasiou Athanasios, Rigakos Georgios, Xanthakis Ioannis, Fostira Florentia, Kotoula Vassiliki, Fountzilas George, Patsalis Philippos |
The Molecular Landscape of Gastric Cancers for Novel Targeted Therapies from Real-World Genomic Profiling. Targeted oncology 2024 4 . Hiroyuki Yamamoto, Hiroyuki Arai, Ritsuko Oikawa, Kumiko Umemoto, Hiroyuki Takeda, Takuro Mizukami, Yohei Kubota, Ayako Doi, Yoshiki Horie, Takashi Ogura, Naoki Izawa, Jay A Moore, Ethan S Sokol, Yu Sunaka |
TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort. Advances in therapy 2024 1 . Sergio D Cruz-Romero, Sebastián González, José Y Juez, David S Becerra, Ana M Baldión, José A Hakim, Deyanira González-Devia, Sandra Perdomo, Paula A Rodríguez-Urre |
GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning. Scientific reports 2024 1 14 (1): 2126. Shuhua Zheng, Nikhil Rammohan, Timothy Sita, P Troy Teo, Yilin Wu, Maciej Lesniak, Sean Sachdev, Tarita O Thom |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: